Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedDifference3%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no visible changes to study content or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedAdded a note that PubMed publications are automatically filled from PubMed and included a Revision: v3.3.1 tag. Updated the PubMed publication description (deletions) to reflect a new wording and Revision: v3.2.0.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the government funding outage notice that previously appeared on the page. The study details and eligibility criteria remain unchanged.SummaryDifference0.2%

- Check62 days agoChange DetectedNo core study content was altered; formatting and UI changes were made that do not affect the study details, eligibility criteria, outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedUpdate: publication date changed from August 28, 2025 (Online ahead of print) to August 28, 2025 with the notice removed; the entry now reflects the standard citation without the Online ahead of print note. Core bibliographic details remain the same.SummaryDifference0.2%

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.